Efficacy and safety of Molnupiravir in COVID-19 patients: a systematic review

BACKGROUND: Molnupiravir is an oral antiviral drug that received Emergency Use Authorization in three countries for the treatment of mild COVID-19. The aim of this systematic review was to find out the safety and efficacy of Molnupiravir in SARS-COV-2 infections. METHODS: The electronic databases su...

Descripción completa

Detalles Bibliográficos
Autores principales: Mali, Kalpana Ramanna, Eerike, Madhavi, Raj, Gerard Marshall, Bisoi, Debasis, Priyadarshini, Rekha, Ravi, Gandham, Chaliserry, Leo Francis, Janti, Siddharam S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463664/
https://www.ncbi.nlm.nih.gov/pubmed/36087236
http://dx.doi.org/10.1007/s11845-022-03139-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463664/
https://www.ncbi.nlm.nih.gov/pubmed/36087236
http://dx.doi.org/10.1007/s11845-022-03139-y

Ejemplares similares